3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pituitary Neoplasms
7
Neuroendocrine Tumors
6
Carcinoid Tumor
5
Acromegaly
5
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Gastro-enteropancreatic neuroendocrine tumor
3
Pituitary ACTH Hypersecretion
2
Neoplasms
2
Neoplasm Metastasis
2
Nelson Syndrome
2
Multiple Myeloma
2
Liver Neoplasms
2
Growth Disorders
2
Gigantism
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
ACTH Syndrome, Ectopic
2
Uveal Melanoma
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Serotonin Syndrome
1
Sarcoma, Synovial
1
Prolactinoma
1
Prolactin-Producing Pituitary Tumor
1
Primary Inoperable Thymoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pancreatic Fistula
1
Neuroectodermal Tumors, Primitive
1
Interventions
Cyclophosphamide
10
Doxorubicin
9
Vincristine
7
Etoposide
7
Ifosfamide
6
Filgrastim
5
Radiotherapy
4
fludarabine phosphate
3
Topotecan
3
Thiotepa
3
Temozolomide
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Irinotecan
3
Cisplatin
3
Carboplatin
3
Brachytherapy
3
seclidemstat
2
Tacrolimus
2
PM 01183
2
Neoadjuvant Therapy
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Epirubicin
2
Dactinomycin
2
Cytoreduction Surgical Procedures
2
Cyclosporine
2
Chemotherapy, Adjuvant
2
thymoglobulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Desmoplastic Small Round Cell Tumor
×
pasireotide
×
Clear all
NCT06456359
2025-01-13
PAMSARC
University Hospital Heidelberg
Phase 2
Recruiting
28 enrolled